Sensei Biotherapeutics, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
SNSE on Nasdaq
Industry
Pharmaceutical Preparations
Location
1405 Research Blvd, Suite 125, Rockville, MD

There are no Buy or Sell transactions made by insiders since 11/21/2023

Sensei Biotherapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Cambrian BioPharma Inc 10%+ Owner $3.11M Jun 11, 2024
James Peyer Director, 10%+ Owner $3.11M Jun 11, 2024
Thomas G. Ricks Director $292K Jun 11, 2024
John Celebi PRESIDENT AND CEO, Director $83.3K Feb 15, 2024
Robert Hamilton Pierce Chief R&D Officer $80.3K Feb 15, 2022
Erin Colgan Chief Financial Officer $53.3K Feb 15, 2024
Edward van der Horst Chief Scientific Officer $44.3K Feb 15, 2024
Patrick Stephen Gallagher Chief Business Officer $29K Feb 15, 2023
Bob Holmen Director $21.8K Jun 11, 2024
William R. Ringo Director $19.9K Jun 11, 2024
Jessie English Director $7.59K Jun 11, 2024
Samuel Broder Director $7.59K Jul 10, 2023
Kristian Humer Director $7.59K Jun 11, 2024
Deneen Vojta Director $7.59K Jun 11, 2024
David Gaiero Principal Financial Officer May 10, 2024
Apeiron Investment Group Ltd. 10%+ Owner Jun 1, 2023
Stephanie Krebs Chief Business Officer Nov 1, 2023
Josiah Craver Principal Financial Officer Sep 17, 2024

Recent Insider Transactions by Companies or Individuals for Sensei Biotherapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.